Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
03/2014
03/06/2014WO2013184646A3 Dosing regimens for subcutaneously infusible acidic compositions
03/06/2014WO2013173759A3 Macrocyclic nucleoside phosphoramidate derivatives
03/06/2014WO2013166563A9 Method for producing a plant extract from desmodium and its extract
03/06/2014WO2013156867A3 Methods and pharmaceutical compositions for the treatment of hypertension
03/06/2014WO2013144931A3 Tcr/mhcii-collagen interaction inhibitors useful for the treatment of rheumatoid arthritis
03/06/2014WO2013134336A3 Inhibition of adaptor associated kinase 1 for the treatment of pain
03/06/2014WO2013120104A3 Modulators of methyl modifying enzymes, compositions and uses thereof
03/06/2014WO2013079623A9 Vicenin 2 and analogues thereof for use as an antispasmodic and/or prokinetic agent
03/06/2014WO2012103051A3 6-amino-2-substituted-5-vinylsilylpyrimidine-4-carboxylic acids and esters and 4-amino-6-substituted-3-vinylsilylpyridine-2-carboxylic acids and esters as herbicides
03/06/2014WO2012075107A3 Active enantiomer of dodecyl 2-(n,n-dimethylamino)-propionate
03/06/2014US20140066657 Dosage regimen for a s1p receptor agonist
03/06/2014US20140066623 Ribosome Structure and Protein Synthesis Inhibitors
03/06/2014US20140066618 Method Of Forming An Aerosol For Inhalation Delivery
03/06/2014US20140066587 Novel Biodegradable Elastomeric Scaffold for Tissue Engineering and Light Scattering Fingerprinting Methods for Testing the Same
03/06/2014US20140066520 Novel anti-inflammatory cyclooxygenase inhibitors
03/06/2014US20140066519 Use of xanthohumol and/or isoxanthohumol as an agent for preventing and/or combating liver diseases
03/06/2014US20140066518 Use of a sprayable composition comprising ambroxol
03/06/2014US20140066517 Use of calixarenes associated with an antibotic in the treatment of bacterial infections
03/06/2014US20140066516 Novel Method
03/06/2014US20140066515 Methods for treating channelopathies
03/06/2014US20140066514 Veterinary Compositions For Controlling Ecto- And Endoparasites In Bovines, Use Of These Compositions, Use Of IGR Substances Associated With Microminerals, Method For Controlling Ecto- And Endoparasites In Bovines And Kit
03/06/2014US20140066513 Methods for compositions for the treatment of irritable bowel syndrome
03/06/2014US20140066512 Oral compositions comprising creatine
03/06/2014US20140066511 Topical delivery of l-arginine to cause beneficial effects
03/06/2014US20140066510 Oat extracts: refining, compositions and methods of use
03/06/2014US20140066508 Metabolic syndrome ameliorating agent
03/06/2014US20140066507 Cosmetic compositions comprising epa and salicylic acid and methods of making and using same
03/06/2014US20140066506 Method for treating macular degeneration
03/06/2014US20140066505 Utilization of Dialkylfumarates
03/06/2014US20140066503 Methods for treating tachycardia and/or controlling heart rate while minimizing and/or controlling hypotension
03/06/2014US20140066502 Use of Stabilized Granules Containing Glyceryl Trinitrate for Arteriogenesis
03/06/2014US20140066497 Treatment of immune dysregulation using cannabinoid derivatives
03/06/2014US20140066496 Composition and Methods for Anti-Macrofouling Treatment of Polymers
03/06/2014US20140066495 Transmucosal administration of taxanes
03/06/2014US20140066494 Acne treatment
03/06/2014US20140066493 Compositions and methods for treatment of ear disorders
03/06/2014US20140066488 Inhibitors of Memapsin 2 Cleavage for the Treatment of Alzheimer's Disease
03/06/2014US20140066487 Antiviral compounds and methods
03/06/2014US20140066485 Medicaments containing famotidine and ibuprofen and administration of same
03/06/2014US20140066484 Methods of administering pirfenidone therapy
03/06/2014US20140066483 Method of activating regulatory t cells with alpha-2b adrenergic receptor agonists
03/06/2014US20140066482 Pharmaceutical Formulation Comprising Metformin and Repaglinide
03/06/2014US20140066481 Water-Free Pharmaceutical Compositions Suitable for Local Anaesthetics
03/06/2014US20140066480 Methods and materials for assessing responsiveness to lenalidomide, thalidomide, and/or other thalidomide analogs
03/06/2014US20140066478 Beta2-Adrenoreceptor Agonists
03/06/2014US20140066476 Modulators of cellular adhesion
03/06/2014US20140066475 Method For Treating Pruritus
03/06/2014US20140066474 Combination of phosphatidylinositol-3-kinase (pi3k) inhibitor and a mtor inhibitor
03/06/2014US20140066473 Modified release compositions comprising tacrolimus
03/06/2014US20140066472 Methods of preventing the development of mucositis and related disorders
03/06/2014US20140066469 Treatment of diseases associated with inflammation
03/06/2014US20140066468 Amorphous form of lopinavir and ritonavir mixture
03/06/2014US20140066467 Use of opioid antagonists to attenuate endothelial cell proliferation and migration
03/06/2014US20140066465 CANCER TREATMENT USING TYROSINE KINASE AND NF-kB INHIBITORS
03/06/2014US20140066464 Methods of diagnosing and treating cancer
03/06/2014US20140066462 Treatment of polycystic disease
03/06/2014US20140066461 Methods for diagnosing and treating schizophrenia
03/06/2014US20140066459 Tetrahydroquinoline derivatives useful as bromodomain inhibitors
03/06/2014US20140066456 Combination therapy in treatment of cancer and fibrotic diseases
03/06/2014US20140066454 Antibiotic Tolerance Inhibitors
03/06/2014US20140066452 Transdermal delivery of beneficial substances effected by a hostile biophysical environment
03/06/2014US20140066451 Thioxanthene derivatives for the treatment of infectious diseases
03/06/2014US20140066449 Dipyridinium derivatives
03/06/2014US20140066447 Immediate release pharmaceutical formulation of 4-[3-(4-cyclopropanecarbonyl-piperazine-1-carbonyl)-4-fluoro-benzyl]-2h-phthalazin-1-one
03/06/2014US20140066446 2,5-disubstituted arylsulfonamide ccr3 antagonists
03/06/2014US20140066444 Method of Treating Cancer
03/06/2014US20140066441 Aerosolized fluoroquinolones and uses thereof
03/06/2014US20140066440 Highly Concentrated Stable Meloxicam Solutions for Needleless Injection
03/06/2014US20140066439 Osteoclast activity
03/06/2014US20140066438 Dopamine receptor d2 antagonist for prevention and treatment of flavivirus infection
03/06/2014US20140066437 Oxathiazine derivatives which are substituted with benzyl or heteromethylene groups, method for producing them, their use as medicine and drug containing said derivatives and the use thereof
03/06/2014US20140066431 Benzoxazepines as Inhibitors of PI3K/mTOR and Methods of Their Use and Manufacture
03/06/2014US20140066429 Dihydropyridophthalazinone inhibitors of poly(adp-ribose)polymerase (parp) for use in treatment of diseases associated with a pten deficiency
03/06/2014US20140066424 Heterocyclic modulators of hif activity for treatment of disease
03/06/2014US20140066421 Oximes for treatment of peripheral and central nervous system exposure to acetyl cholinesterase inhibitors
03/06/2014US20140066417 Anaesthetic formulation
03/06/2014US20140066415 Methods and Compounds for Vitamin D Therapy
03/06/2014US20140066414 Topical compositions for treatment of skin conditions
03/06/2014US20140066413 Analgesic composition and method of making the same
03/06/2014US20140066412 Heteroaryl substituted urea modulators of fatty acid amide hydrolase
03/06/2014US20140066407 Fungicide Active Substance Combinations
03/06/2014US20140066403 Hydrophilic modified polyrotaxane composition
03/06/2014US20140066402 Pharmaceutical Compositions with Glycosaminoglycans and Use Thereof in the Treatment of Chronic Ulcers
03/06/2014US20140066399 Pharmacological preparation for topical use containing npalmitoyl-vanillamide
03/06/2014US20140066398 Hcv polymerase inhibitors
03/06/2014US20140066397 Method for treating neurotrauma
03/06/2014US20140066396 Method of inhibiting hepatitus c virus by combination of a 5,6-dihydro-1h-pyridin-2-one and one or more additional antiviral compounds
03/06/2014US20140066395 Purine nucleoside monophosphate prodrugs for treatment of cancer and viral infections
03/06/2014US20140066392 Combination treatments for melanoma
03/06/2014US20140066389 Method and pharmaceutical to treat spinal discs
03/06/2014US20140066386 Therapies for hematologic malignancies
03/06/2014US20140066385 Method for treating cancer by combined use of drugs
03/06/2014US20140066383 Methods of treating cancer
03/06/2014US20140066372 Glucokinase Activator Compositions for the Treatment of Diabetes
03/06/2014US20140066369 Modulators Of The GPR119 Receptor And The Treatment Of Disorders Related Thereto
03/06/2014US20140066365 Use of calixarenes associated with an antibiotic in the treatment of bacterial infections
03/06/2014US20140066364 Cyanoacrylate tissue adhesives
03/06/2014US20140065248 Medical electrode
03/06/2014US20140065246 Intracellular calcium modulation for cancer treatment
03/06/2014US20140065245 Method for preparing dietary supplements
1 ... 358 359 360 361 362 363 364 365 366 367 368 369 370 371 372 373 374 375 376 377 378 ... 7860